extendicare inc. - EXETF

EXETF

Close Chg Chg %
16.19 -0.19 -1.19%

Closed Market

16.00

-0.19 (1.19%)

Volume: 12.89K

Last Updated:

Dec 23, 2025, 1:44 PM EDT

Company Overview: extendicare inc. - EXETF

EXETF Key Data

Open

$16.00

Day Range

16.00 - 16.00

52 Week Range

6.72 - 16.59

Market Cap

$1.34B

Shares Outstanding

83.82M

Public Float

82.66M

Beta

0.93

Rev. Per Employee

N/A

P/E Ratio

20.19

EPS

$0.77

Yield

226.44%

Dividend

$0.03

EX-DIVIDEND DATE

Dec 31, 2025

SHORT INTEREST

N/A

AVERAGE VOLUME

2.88K

 

EXETF Performance

1 Week
 
0.25%
 
1 Month
 
9.59%
 
3 Months
 
47.19%
 
1 Year
 
124.03%
 
5 Years
 
203.61%
 

EXETF Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings
Full Ratings ➔

About extendicare inc. - EXETF

Extendicare, Inc. engages in the provision of nursing care, home health care, retirement living, and management and consulting services. It operates through the following business segments: Long-Term Care, Home Health Care, and Managed Services. The Long-Term Care segment includes government funded designated supportive living home and private pay retirement wings. The Home Health Care segment involves providing services through ParaMed. The Managed Services segment refers to the third parties and joint ventures. The company was founded by Harold Livergant and John MacKay on August 7, 1968 and is headquartered in Markham, Canada.

EXETF At a Glance

Extendicare, Inc.
3000 Steeles Avenue East
Markham, Ontario L3R 4T9
Phone 1-905-470-4000 Revenue 1.07B
Industry Hospital/Nursing Management Net Income 54.90M
Sector Health Services 2024 Sales Growth 10.694%
Fiscal Year-end 12 / 2025 Employees N/A
View SEC Filings

EXETF Valuation

P/E Current 20.19
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 11.338
Price to Sales Ratio 0.659
Price to Book Ratio 7.135
Price to Cash Flow Ratio 6.76
Enterprise Value to EBITDA 7.80
Enterprise Value to Sales 0.769
Total Debt to Enterprise Value 0.247

EXETF Efficiency

Revenue/Employee N/A
Income Per Employee N/A
Receivables Turnover 16.672
Total Asset Turnover 2.118

EXETF Liquidity

Current Ratio 0.832
Quick Ratio 0.832
Cash Ratio 0.418

EXETF Profitability

Gross Margin 11.458
Operating Margin 7.574
Pretax Margin 6.679
Net Margin 5.13
Return on Assets 10.864
Return on Equity 71.697
Return on Total Capital 18.941
Return on Invested Capital 19.145

EXETF Capital Structure

Total Debt to Total Equity 235.209
Total Debt to Total Capital 70.168
Total Debt to Total Assets 40.635
Long-Term Debt to Equity 210.205
Long-Term Debt to Total Capital 62.709
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Extendicare Inc. - EXETF

Collapse All in section
All values USD millions. 2021 2022 2023 2024 5-year trend
Sales/Revenue
970.51M 938.34M 966.86M 1.07B
Sales Growth
+12.38% -3.31% +3.04% +10.69%
Cost of Goods Sold (COGS) incl D&A
883.99M 879.32M 879.11M 947.62M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
30.21M 24.35M 24.15M 24.45M
Depreciation
- - - 19.27M
-
Amortization of Intangibles
- - - 4.88M
-
COGS Growth
+16.80% -0.53% -0.02% +7.79%
Gross Income
86.52M 59.02M 87.74M 122.63M
Gross Income Growth
-18.91% -31.79% +48.68% +39.76%
Gross Profit Margin
+8.91% +6.29% +9.08% +11.46%
2021 2022 2023 2024 5-year trend
SG&A Expense
41.82M 39.23M 41.37M 41.56M
Research & Development
- - - -
-
Other SG&A
41.82M 39.23M 41.37M 41.56M
SGA Growth
+14.57% -6.19% +5.45% +0.47%
Other Operating Expense
- - - -
-
Unusual Expense
10.50M 10.48M 8.75M 6.35M
EBIT after Unusual Expense
34.19M 9.30M 37.63M 74.71M
Non Operating Income/Expense
291.93K 3.91M 11.28M 12.17M
Non-Operating Interest Income
1.49M 3.85M 4.59M 5.14M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
21.69M 16.67M 15.73M 15.40M
Interest Expense Growth
+2.18% -23.17% -5.61% -2.12%
Gross Interest Expense
21.69M 16.67M 15.73M 15.40M
Interest Capitalized
- - - -
-
Pretax Income
12.79M (3.45M) 33.18M 71.48M
Pretax Income Growth
-70.86% -127.00% +1,060.76% +115.44%
Pretax Margin
+1.32% -0.37% +3.43% +6.68%
Income Tax
5.60M 11.52K 8.02M 17.99M
Income Tax - Current - Domestic
6.81M 2.42M 5.05M 19.89M
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
(1.21M) (2.41M) 2.97M (1.89M)
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
7.19M (3.47M) 25.18M 54.90M
Minority Interest Expense
- - - -
-
Net Income
7.19M (3.47M) 25.18M 54.90M
Net Income Growth
-77.36% -148.21% +826.62% +118.04%
Net Margin Growth
+0.74% -0.37% +2.60% +5.13%
Extraordinaries & Discontinued Operations
- - 1.99M (132.12K)
-
Discontinued Operations
- - 1.99M (132.12K)
-
Net Income After Extraordinaries
9.18M (3.60M) 25.18M 54.90M
Preferred Dividends
- - - -
-
Net Income Available to Common
9.18M (3.60M) 25.18M 54.90M
EPS (Basic)
0.102 -0.0404 0.2963 0.6519
EPS (Basic) Growth
-77.33% -139.61% +833.42% +120.01%
Basic Shares Outstanding
89.99M 89.01M 84.99M 84.22M
EPS (Diluted)
0.102 -0.0404 0.2963 0.5757
EPS (Diluted) Growth
-77.33% -139.61% +833.42% +94.30%
Diluted Shares Outstanding
89.99M 89.01M 84.99M 95.36M
EBITDA
74.91M 44.13M 70.53M 105.51M
EBITDA Growth
-24.53% -41.08% +59.80% +49.61%
EBITDA Margin
+7.72% +4.70% +7.29% +9.86%

Extendicare Inc. in the News